Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Pharma Mar Research and Development Expense (Annual) : 104.94M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 104.94M |
| December 31, 2024 | 107.84M |
| December 31, 2023 | 104.87M |
| December 31, 2022 | 85.53M |
| December 31, 2021 | 83.10M |
| December 31, 2020 | 57.19M |
| December 31, 2019 | 51.74M |
| December 31, 2018 | 81.54M |
| December 31, 2017 | 88.59M |
| December 31, 2016 | 81.49M |
| December 31, 2015 | 62.26M |
| December 31, 2014 | 57.45M |
| December 31, 2013 | 47.44M |
| Date | Value |
|---|---|
| December 31, 2012 | 48.66M |
| December 31, 2011 | 78.80M |
| December 31, 2010 | 73.68M |
| December 31, 2009 | 74.18M |
| December 31, 2008 | 84.19M |
| December 31, 2007 | 70.76M |
| December 31, 2006 | 62.39M |
| December 31, 2005 | 56.74M |
| December 31, 2004 | 45.66M |
| December 31, 2003 | 57.95M |
| December 31, 2002 | 42.23M |
| December 31, 2001 | 28.72M |
| December 31, 2000 | 0.1113M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Oryzon Genomics SA | 14.22M |
| Grifols SA | 420.96M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alkermes Plc | 318.36M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |